Ruairidh Milne
@ruairidhm.bsky.social
Long Covid since March 2020.
“Nothing about me without me” - doesn't seem unreasonable.
Previously: health research, public health, technology assessment and appraisal
Also some Shetland!
“Nothing about me without me” - doesn't seem unreasonable.
Previously: health research, public health, technology assessment and appraisal
Also some Shetland!
That's wonderful to know, Ian!
December 13, 2025 at 11:25 AM
That's wonderful to know, Ian!
Reposted by Ruairidh Milne
7/ The UK must choose:
🔹 A public health system balancing innovation & affordability
OR
🔹 A US-style model of soaring costs & widening inequalities.
Transparency & accountability are non-negotiable.
Read the full article here: www.bmj.com/content/391/...
🔹 A public health system balancing innovation & affordability
OR
🔹 A US-style model of soaring costs & widening inequalities.
Transparency & accountability are non-negotiable.
Read the full article here: www.bmj.com/content/391/...
Who are the winners and losers of the UK-US pharma deal—it depends which side you believe
Behind the UK’s “landmark” pharma deal with the US lies a costly surrender, with higher drug prices, weaker safeguards, and vague promises of investment, write Els Torreele and Martin McKee
When the...
www.bmj.com
December 5, 2025 at 10:41 AM
7/ The UK must choose:
🔹 A public health system balancing innovation & affordability
OR
🔹 A US-style model of soaring costs & widening inequalities.
Transparency & accountability are non-negotiable.
Read the full article here: www.bmj.com/content/391/...
🔹 A public health system balancing innovation & affordability
OR
🔹 A US-style model of soaring costs & widening inequalities.
Transparency & accountability are non-negotiable.
Read the full article here: www.bmj.com/content/391/...
Reposted by Ruairidh Milne
6/ Big selling point - increase in NICE cost effectiveness threshold. But £30k to £35k a 16% increase and if prices increase by 25%, well ... something commentators seem to have missed (emphasising need to question what one is told)
December 5, 2025 at 10:41 AM
6/ Big selling point - increase in NICE cost effectiveness threshold. But £30k to £35k a 16% increase and if prices increase by 25%, well ... something commentators seem to have missed (emphasising need to question what one is told)
thank you both for what you do!
December 5, 2025 at 7:13 AM
thank you both for what you do!